Variables | DFS (n=136) | OS (n=136) | ||
---|---|---|---|---|
 | HR (95% CI) | P | HR (95% CI) | P |
Age, years (≤62/>62) | 0.682 (0.462-1.005) | 0.053 | 0.714 (0.483-1.054) | 0.090 |
Gender (male/female) | 0.452 (0.256-0.798) | 0.006* | 0.417 (0.232-0.747) | 0.003* |
WHO Grade (1/2/3) | 1.362 (1.053-1.763) | 0.019* | 1.324 (1.023-1.715) | 0.033* |
Tumor (T) status (1-2/3-4) | 1.569 (1.019-2.416) | 0.041* | 1.508 (0.976-2.332) | 0.064 |
Nodal (N) status (0/1) | 2.095 (1.415-3.101) | <0.001* | 1.998 (1.346-2.965) | 0.001* |
TNM stage (I-II/III-IV) | 1.346 (1.110-1.633) | 0.003* | 1.318 (1.085-1.601) | 0.005* |
MIF in tumor cells (low/high) | 1.518 (1.028-2.242) | 0.036* | 1.532 (1.034-2.269) | 0.033* |
CXCR4 in tumor cells (low/high) | 1.537 (1.035-2.283) | 0.033* | 1.550 (1.041-2.307) | 0.031* |
MIF in lymphocytes (low/high) | 1.548 (1.053-2.275) | 0.026* | 1.481 (1.003-2.185) | 0.048* |
CXCR4 in lymphocytes (low/high) | 0.738 (0.501-1.085) | 0.122 | 0.715 (0.485-1.055) | 0.091 |